{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T04:47:49Z","timestamp":1771476469763,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"39","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.vaccine.2021.08.031","type":"journal-article","created":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T19:36:52Z","timestamp":1629142612000},"page":"5580-5588","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Therapeutic activity of a Salmonella-vectored Schistosoma mansoni vaccine in a mouse model of chronic infection"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4092-7172","authenticated-orcid":false,"given":"Adam S.","family":"Hassan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0874-7251","authenticated-orcid":false,"given":"Dilhan J.","family":"Perera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian J.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9012-4212","authenticated-orcid":false,"given":"Momar","family":"Ndao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.08.031_b0005","doi-asserted-by":"crossref","unstructured":"McManus DP, Bergquist R, Cai P, Ranasinghe S, Tebeje BM, You H. Schistosomiasis\u2014from immunopathology to vaccines [Internet]. Vol. 42, Seminars in Immunopathology. Springer; 2020 [cited 2020 Nov 8]. p. 355\u201371. Available from: \/pmc\/articles\/PMC7223304\/?report=abstract","DOI":"10.1007\/s00281-020-00789-x"},{"key":"10.1016\/j.vaccine.2021.08.031_b0010","doi-asserted-by":"crossref","unstructured":"McManus DP. Recent Progress in the Development of Liver Fluke and Blood Fluke Vaccines. Vaccines [Internet]. 2020 Sep 22 [cited 2020 Nov 27];8(3):553. Available from: https:\/\/www.mdpi.com\/2076-393X\/8\/3\/553","DOI":"10.3390\/vaccines8030553"},{"key":"10.1016\/j.vaccine.2021.08.031_b0015","doi-asserted-by":"crossref","unstructured":"Schwartz C, Fallon PG. Schistosoma \u201cEggs-iting\u201d the host: Granuloma formation and egg excretion. Vol. 9, Frontiers in Immunology. Frontiers Media S.A.; 2018.","DOI":"10.3389\/fimmu.2018.02492"},{"key":"10.1016\/j.vaccine.2021.08.031_b0020","doi-asserted-by":"crossref","unstructured":"Cioli D, Pica-Mattoccia L, Basso A, Guidi A. Schistosomiasis control: Praziquantel forever? [Internet]. Vol. 195, Molecular and Biochemical Parasitology. Elsevier; 2014 [cited 2020 Dec 13]. p. 23\u20139. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/24955523\/","DOI":"10.1016\/j.molbiopara.2014.06.002"},{"key":"10.1016\/j.vaccine.2021.08.031_b0025","doi-asserted-by":"crossref","unstructured":"Couto FFB, Coelho PMZ, Ara\u00fajo N, Kusel JR, Katz N, Jannotti-Passos LK, et al. Schistosoma mansoni: A method for inducing resistance to praziquantel using infected Biomphalaria glabrata snails. Mem Inst Oswaldo Cruz [Internet]. 2011 [cited 2020 Dec 13];106(2):153\u20137. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/21537673\/","DOI":"10.1590\/S0074-02762011000200006"},{"key":"10.1016\/j.vaccine.2021.08.031_b0030","doi-asserted-by":"crossref","unstructured":"Molehin AJ. Current Understanding of Immunity Against Schistosomiasis: Impact on Vaccine and Drug Development. 2020 [cited 2020 Nov 23]; Available from: http:\/\/doi.org\/10.2147\/RRTM.S274518","DOI":"10.2147\/RRTM.S274518"},{"key":"10.1016\/j.vaccine.2021.08.031_b0035","doi-asserted-by":"crossref","unstructured":"Hassan AS, Zelt NH, Perera DJ, Ndao M, Ward BJ. Vaccination against the digestive enzyme Cathepsin B using a YS1646 Salmonella enterica Typhimurium vector provides almost complete protection against Schistosoma mansoni challenge in a mouse model. Yang R, editor. PLoS Negl Trop Dis [Internet]. 2019 Dec 2;13(12):e0007490. Available from: https:\/\/dx.plos.org\/10.1371\/journal.pntd.0007490","DOI":"10.1371\/journal.pntd.0007490"},{"issue":"2","key":"10.1016\/j.vaccine.2021.08.031_b0040","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.molbiopara.2005.06.007","article-title":"Long-term suppression of cathepsin B levels by RNA interference retards schistosome growth","volume":"143","author":"Correnti","year":"2005","journal-title":"Mol Biochem Parasitol"},{"issue":"1","key":"10.1016\/j.vaccine.2021.08.031_b0045","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0166-6851(03)00194-4","article-title":"Functional expression and characterization of Schistosoma mansoni cathepsin B and its trans-activation by an endogenous asparaginyl endopeptidase","volume":"131","author":"Sajid","year":"2003","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.vaccine.2021.08.031_b0050","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiu031","article-title":"Use of an Sm-p80-Based Therapeutic Vaccine to Kill Established Adult Schistosome Parasites in Chronically Infected Baboons","author":"Karmakar","year":"2014","journal-title":"J Infect Dis."},{"issue":"2","key":"10.1016\/j.vaccine.2021.08.031_b0055","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.vaccine.2014.11.016","article-title":"Evaluation of the immune response and protective efficacy of Schistosoma mansoni Cathepsin B in mice using CpG dinucleotides as adjuvant","volume":"33","author":"Ricciardi","year":"2015","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2021.08.031_b0060","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00089-19","article-title":"Vaccination against clostridium difficile by use of an attenuated salmonella enterica serovar typhimurium vector (YS1646) protects mice from lethal challenge","volume":"87","author":"Winter","year":"2019","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2021.08.031_b0065","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.605288","article-title":"Adjuvanted Schistosoma mansoni-Cathepsin B With Sulfated Lactosyl Archaeol Archaeosomes or AddaVaxTM Provides Protection in a Pre-Clinical Schistosomiasis Model","author":"Perera","year":"2020","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2021.08.031_b0070","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-016-1444-z","article-title":"A vaccine consisting of Schistosoma mansoni cathepsin B formulated in Montanide ISA 720 VG induces high level protection against murine schistosomiasis","volume":"16","author":"Ricciardi","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2021.08.031_b0075","doi-asserted-by":"crossref","unstructured":"Takaki KK, Rinaldi G, Berriman M, Pag\u00e1 AJ, Ramakrishnan L. Schistosoma mansoni Eggs Modulate the Timing of Granuloma Formation to Promote Transmission. Cell Host Microbe [Internet]. 2021 [cited 2021 Mar 2];29:58\u201367. Available from: https:\/\/doi.org\/10.1016\/j.chom.2020.10.002","DOI":"10.1016\/j.chom.2020.10.002"},{"key":"10.1016\/j.vaccine.2021.08.031_b0080","doi-asserted-by":"crossref","unstructured":"Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, et al. Defective LPS signaling in C3H\/HeJ and C57BL\/10ScCr mice: Mutations in Tlr4 gene. Science (80-) [Internet]. 1998 Dec 11 [cited 2020 Dec 14];282(5396):2085\u20138. Available from: http:\/\/science.sciencemag.org\/","DOI":"10.1126\/science.282.5396.2085"},{"key":"10.1016\/j.vaccine.2021.08.031_b0085","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.micpath.2018.03.016","article-title":"Expression of Salmonella typhimurium and Escherichia coli flagellin protein and its functional characterization as an adjuvant","volume":"118","author":"Makvandi","year":"2018","journal-title":"Microb Pathog."},{"key":"10.1016\/j.vaccine.2021.08.031_b0090","doi-asserted-by":"crossref","unstructured":"McManus DP, Loukas A. Current status of vaccines for schistosomiasis [Internet]. Vol. 21, Clin Microbiol Rev. Am Soc Microbiol J; 2008 [cited 2020 Dec 14]. p. 225\u201342. Available from: http:\/\/cmr.asm.org\/","DOI":"10.1128\/CMR.00046-07"},{"key":"10.1016\/j.vaccine.2021.08.031_b0095","doi-asserted-by":"crossref","unstructured":"Hewitson JP, Hamblin PA, Mountford AP. Immunity induced by the radiation-attenuated schistosome vaccine. Parasite Immunol [Internet]. 2005 Jul 1 [cited 2020 Dec 14];27(7\u20138):271\u201380. Available from: http:\/\/doi.wiley.com\/10.1111\/j.1365-3024.2005.00764.x","DOI":"10.1111\/j.1365-3024.2005.00764.x"},{"key":"10.1016\/j.vaccine.2021.08.031_b0100","article-title":"T Lymphocyte-Mediated Liver Immunopathology of Schistosomiasis","volume":"11","author":"Zheng","year":"2020","journal-title":"Front Immunol Front Media S.A"},{"issue":"1","key":"10.1016\/j.vaccine.2021.08.031_b0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085401","article-title":"Cysteine peptidases as schistosomiasis vaccines with inbuilt adjuvanticity","volume":"9","author":"El Ridi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2021.08.031_b0110","doi-asserted-by":"crossref","unstructured":"Colley DG, Secor WE. Immunology of human schistosomiasis. Vol. 36, Parasite Immunology. Blackwell Publishing Ltd; 2014. p. 347\u201357.","DOI":"10.1111\/pim.12087"},{"key":"10.1016\/j.vaccine.2021.08.031_b0115","doi-asserted-by":"crossref","unstructured":"de Melo TT, de Sena IC, Araujo N, Fonseca CT. Antibodies are involved in the protective immunity induced in mice by Schistosoma mansoni schistosomula tegument (Smteg) immunization. Parasite Immunol [Internet]. 2014 Feb [cited 2020 Dec 14];36(2):107\u201311. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/24558655\/","DOI":"10.1111\/pim.12091"},{"key":"10.1016\/j.vaccine.2021.08.031_b0120","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01710","article-title":"Immune mechanisms involved in schistosoma mansoni-Cathepsin B vaccine induced protection in mice","author":"Ricciardi","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2021.08.031_b0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000290","article-title":"Elimination of Schistosoma mansoni adult worms by rhesus macaques: Basis for a therapeutic vaccine?","author":"Wilson","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2021.08.031_b0130","doi-asserted-by":"crossref","first-page":"e0003925","DOI":"10.1371\/journal.pntd.0003925","article-title":"Evidence That Rhesus Macaques Self-Cure from a Schistosoma japonicum Infection by Disrupting Worm Esophageal Function: A New Route to an Effective Vaccine?","volume":"9","author":"Li","year":"2015","journal-title":"Dalton JP, editor. PLoS Negl Trop Dis [Internet]."},{"issue":"1","key":"10.1016\/j.vaccine.2021.08.031_b0135","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jaci.2012.04.027","article-title":"Generalized urticaria induced by the Na-ASP-2 hookworm vaccine: Implications for the development of vaccines against helminths","volume":"130","author":"Diemert","year":"2012","journal-title":"J Allergy Clin Immunol."},{"key":"10.1016\/j.vaccine.2021.08.031_b0140","doi-asserted-by":"crossref","unstructured":"Cr\u00e9pin S, Harel S, Dozois CM. Chromosomal complementation using Tn7 transposon vectors in enterobacteriaceae. Appl Environ Microbiol [Internet]. 2012 Sep [cited 2020 Dec 14];78(17):6001\u20138. Available from: \/pmc\/articles\/PMC3416591\/?report=abstract","DOI":"10.1128\/AEM.00986-12"},{"key":"10.1016\/j.vaccine.2021.08.031_b0145","doi-asserted-by":"crossref","unstructured":"Toso JF, Gill VJ, Hwu P, Marincola FM, Restifo NP, Schwartzentruber DJ, et al. Phase I Study of the Intravenous Administration of Attenuated Salmonella typhimurium to Patients With Metastatic Melanoma . J Clin Oncol [Internet]. 2002 Jan 1 [cited 2020 Dec 14];20(1):142\u201352. Available from: \/pmc\/articles\/PMC2064865\/?report=abstract","DOI":"10.1200\/JCO.2002.20.1.142"},{"issue":"47","key":"10.1016\/j.vaccine.2021.08.031_b0150","doi-asserted-by":"crossref","first-page":"17915","DOI":"10.1073\/pnas.0604054103","article-title":"Salmonella typhimurium disseminates within its host by manipulating the motility of infected cells","volume":"103","author":"Worley","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.vaccine.2021.08.031_b0155","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1074\/jbc.271.3.1717","article-title":"Cathepsin B of Schistosoma mansoni purification and activation of the recombinant proenzyme secreted by saccharomyces cerevisiae*","volume":"271","author":"Lipps","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2021.08.031_b0160","doi-asserted-by":"crossref","unstructured":"Yadati T, Houben T, Bitorina A, Shiri-Sverdlov R. The Ins and Outs of Cathepsins: Physiological Function and Role in Disease Management [Internet]. Vol. 9, Cells. NLM (Medline); 2020 [cited 2021 Mar 4]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32668602\/","DOI":"10.3390\/cells9071679"},{"key":"10.1016\/j.vaccine.2021.08.031_b0165","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.vaccine.2015.12.032","article-title":"Workshop report: Schistosomiasis vaccine clinical development and product characteristics","author":"Mo","year":"2016","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21010513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21010513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:01:35Z","timestamp":1759402895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21010513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":33,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0264410X21010513"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.08.031","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic activity of a Salmonella-vectored Schistosoma mansoni vaccine in a mouse model of chronic infection","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.08.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}